Low‐dose valganciclovir prophylaxis for cytomegalovirus in intermediate‐risk (R+) renal transplant recipients: Single‐center experience

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 19, Iss. 6, 2017-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased risk of breakthrough infection among cytomegalovirus donor‐positive/recipient‐negative kidney transplant recipients receiving lower‐dose valganciclovir prophylaxis

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 163-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

Leukocyte Depleted, Unscreened Blood Products Give a Low Risk for CMV Infection and Disease in CMV Seronegative Allogeneic Stem Cell Transplant Recipients with Seronegative Stem Cell Donors

By Ljungman Per   Larsson Kajsa   Kumlien Gunilla   Aschan Johan   Barkholt Lisbeth   Gustafsson-Jernberg Åsa   Lewensohn-Fuchs Ilona   Ringdén Olle  

Scandinavian Journal of Infectious Diseases, Vol. 34, Iss. 5, 2002-05 ,pp. : 347-350

Informa Healthcare

Access to resources Recommend Favorite

Functional specific‐T‐cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 19, Iss. 6, 2017-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human cytomegalovirus detection by real-time PCR and pp65-antigen test in hematopoietic stem cell transplant recipients: a challenge in low and middle-income countries

By Breda Giovanni   Almeida Bernado   Carstensen Suzana   Bonfim Carmem M   Nogueira Meri B   Vidal Luine R   Almeida Sergio M   Raboni Sonia M  

Annals of Tropical Medicine and Parasitology, Vol. 107, Iss. 6, 2013-09 ,pp. : 312-319

Maney Publishing

Access to resources Recommend Favorite